Latest Breaking News On - Medtronic pulseselect - Page 4 : comparemela.com

FDA approves Medtronic PulseSelect pulsed field ablation system

The Medtronic (NYSE:MDT) PulseSelect Pulsed Field Ablation System is the first PFA technology approved for use in the U.S. to treat AFib.

Medtronic's PulseSelect PFA System Gets FDA Nod, Revolutionizing Atrial Fibrillation Treatment in US - Medtronic (NYSE:MDT)

The FDA approved Medtronic plc's (NYSE: MDT) PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF), an irregular and often 

Medtronic wins pulsed field ablation CE mark, teeing up 2-front challenge to Boston Scientific

Medtronic received the mark for its single-shot PFA device, clearing the company to expand its portfolio of European atrial fibrillation devices.

Pulsed Field Ablation Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic

/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pulsed Field Ablation Market- By Therapeutic.

InsightAce Analytic Pvt. Ltd: Pulsed Field Ablation Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic